Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

“Worst drug approval decision in recent US history”

June 30, 2021 Research and Development

The FDA’s decision to accelerate approval for Aduhelm, the first new drug for Alzheimer’s in two decades, has been met …
News
img_4190-e1376666350337-web

Sickle cell therapy granted innovation passport by MHRA

June 30, 2021 Research and Development MHRA, SCD, brexit

Bluebird bio has been granted an innovation passport, under the new UK approval process, for LentiGlobin (bb1111) a promising treatment …
News
bms_european_hq_in_rueil_1

EU approves BMS’s treatment for metastatic colorectal cancer

June 30, 2021 Research and Development

The EU has approved Opdivo (nivolumab) plus Yervoy (ipilimumab) for the treatment of metastatic colorectal cancer. The treatment will be …
News
xxx

RNA breakthrough: Fluorescence used to track molecule movement

June 30, 2021 Research and Development AstraZeneca, RNA, mrna

Researchers at Chalmers University of Technology in Sweden have announced a breakthrough in the labelling method of messenger RNA (mRNA) …
News

EU approves Merck’s treatment for oesophageal cancer

June 30, 2021 Research and Development

The EU has approved Merck’s KEYTRUDA, in combination with platinum- and fluoropyrimidine-based chemotherapy, as treatment for advanced oesophageal cancer. The …
News

Anti-parasitic drug investigated as potential COVID treatment

June 23, 2021 Research and Development

The University of Oxford has announced that it has begun investigations into ivermectin, a controversial anti-parasitic drug, as a potential …
News
astrazeneca_sign_sky

AstraZeneca’s lung cancer treatment approved in China

June 23, 2021 Research and Development

AstraZeneca and HUTCHMED’s savolitinib has been granted conditional approval in China for the treatment of patients with non-small cell lung …
News
european_commission_web

Extra 150 million doses of Moderna COVID jab bought by EC

June 23, 2021 Research and Development

Moderna have announced that the European Commission (EC) has purchased an additional 150 million doses of their COVID-19 vaccine, bringing …
News
janssen_latest_logo_on_sign_closer

EU approves Janssen’s treatments for amyloidosis and multiple myeloma

June 23, 2021 Research and Development

The EU has approved Janssen’s DARZALEX SC (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone for the treatment …
News

Vectura announces cannabinoid company collaboration for TBI treatment

June 23, 2021 Research and Development

Vectura have announced the signing of a pre-clinical development agreement with Incannex, an Australian cannabinoid medicines development company, to provide …
News

UK COVID vaccine update

June 16, 2021 Research and Development COVID-19, UK, care homes, children, government, vaccines

Care home staff vaccinations to be compulsory COVID-19 vaccinations among care home staff are to become mandatory, the Guardian has …
News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

June 16, 2021 Research and Development

The past week has seen quite a mixed bag when it comes to COVID-19 news, an AstraZeneca antibody has failed …
News

Ground-breaking COVID antibody treatment proven to save lives

June 16, 2021 Research and Development COVID-19, UK, antibodies, trial

Results from Regeneron’s Recovery trial, investigating a potent monoclonal antibody combination treatment in hospitalised patients with severe COVID-19, have shown …
News

Signite’s sustainable decorating solution to reduce label waste by 50%

June 16, 2021 Research and Development

ACTEGA has officially launched Signite, a new decorating solution designed to significantly reduce waste in label production. The hope is …
News

Avadel’s narcolepsy Phase III trial shows positive results

June 16, 2021 Research and Development

Avadel’s Phase III trial for FT218 in patients with narcolepsy has shown positive results. The data from the trial demonstrated …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026